Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5-7, 2017

Cancer Immunol Immunother. 2019 Jan;68(1):151-158. doi: 10.1007/s00262-018-2222-0. Epub 2018 Aug 9.

¹ Italian Network for Tumor Bio-immunotherapy (NIBIT), Siena, Italy. mmaiocro@gmail.com.
² Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy. mmaiocro@gmail.com.
³ Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, V.le Bracci, 16, Siena, Italy.
⁴ University of Siena, Siena, Italy.
⁵ Italian Network for Tumor Bio-immunotherapy (NIBIT), Siena, Italy.
⁶ Immuno-biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, San Raffaele Hospital Scientific Institute, Milan, Italy.

No abstract available

Keywords: Cancer vaccines; Checkpoint blockade agents; Immunotherapy; NIBIT; Targeted therapies; Tumor microenvironment.

Publication types